Amphetamine Stimulant Prodrug denied as not FDA-approved for this use by Cigna?

Cigna's specific coverage criteria for amphetamine stimulant prodrug are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied This Claim — and Why You Can Fight Back

Cigna may issue a "not FDA-approved" denial for an amphetamine-based stimulant prodrug when the specific formulation, delivery mechanism, or indication on your prescription does not match what Cigna's system maps to an approved use. These denials can also arise from coding mismatches between the prescriber's stated diagnosis and the drug's labeled indications, even when the FDA has in fact cleared the product.

## Is This Denial Appealable?

Yes — and the appeal has strong footing when the drug genuinely holds FDA approval for your diagnosis. The FDA approval record is public and precise; if the denial misclassifies the drug, that factual error is correctable on appeal. Under the Affordable Care Act (ACA §2719) and, for employer-sponsored plans, ERISA §503, you have a federally guaranteed right to a full-and-fair internal review and, if that fails, an independent external review. The external-review window is typically available for up to approximately four months after a final internal denial. An expedited (72-hour) review is available when your condition is urgent.

## Appeal Process and Timeline

1. Request the denial letter in writing. It must state the specific basis for the denial and the clinical criteria applied. 2. File an internal appeal within Cigna's stated deadline (typically 180 days from the denial notice). Cigna must respond within 30 days for pre-service appeals or 60 days for post-service appeals. 3. If internal appeal fails, request external review through the independent review organization (IRO) assigned by Cigna or your state insurance commissioner. 4. Expedited track: If waiting poses a serious risk to your health, request expedited external review — a decision is required within 72 hours.

## Documentation to Gather

• FDA approval confirmation: Print the current FDA label from DailyMed (dailymed.nlm.nih.gov) showing the approved indications that match your diagnosis.
• Diagnosis documentation: Office notes and diagnostic records confirming the condition for which the drug is prescribed falls within a labeled indication.
• Prescriber letter: A medical-necessity letter from your prescriber explicitly stating the diagnosis, why this drug is indicated, and citing the FDA-approved labeling.
• Prior treatment history: Chronological list of treatments tried, with dates and outcomes, to establish clinical context.
• Cigna's own coverage policy: Download Cigna's current medical/pharmacy coverage policy for this drug class and note every criterion listed.

## Criteria-Mapping Structure

Copy each requirement from (a) the FDA prescribing label and (b) Cigna's published coverage policy into a two-column table. In the right column, cite the exact chart entry — date, note, lab, or prescriber statement — that satisfies each requirement. Submit this mapping as an exhibit to your appeal letter. If the denial truly rests on a factual error (the drug is FDA-approved for your diagnosis), state that clearly and attach the FDA label page as Exhibit A.